Buscopan 20mg Injection
PDF Leaflet Revision Date: 19 April 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of gastrointestinal spasm.
Dosage (summary)
Adults: 1 tablet 3 times daily, can increase to 2 tablets 4 times daily.
Special Populations
- Paediatric population
- Impaired metabolic function
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding due to insufficient data.
Key Drug Interactions
- Anticholinergics
- Beta-adrenergic medicines
- Central depressants
Contraindications
- Hypersensitivity
- Myasthenia gravis
- Mechanical stenosis
- Paralytic ileus
- Narrow angle glaucoma
- Porphyria
- Enlarged prostate
- Fever
- Tachycardia
Common side effects
- Tachycardia
- Dry mouth
- Skin reactions
- Urinary retention
Counselling Points
- Do not chew tablets
- Seek medical advice for severe abdominal pain
- Avoid driving if affected by visual disturbances
Serious warnings
- Severe abdominal pain requires medical advice
- Risk of anticholinergic complications
- Caution in narrow angle glaucoma
Important Disclaimer
The Buscopan 20mg Injection professional information leaflet below is the property of Sanofi-Aventis South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
